19 GENES FOUND
Show / hide columns
XML |
RDF |
TSV |
Page
of 1
ABCC2 ATP-binding cassette, sub-family C (CFTR/MRP), member 2 Cancer-related genes Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Group enriched duodenum: 44.7 gallbladder: 42.8 kidney: 20.8 liver: 67.6 small intestine: 50.5
ACE2 Angiotensin I converting enzyme 2 Enzymes FDA approved drug targets Predicted membrane proteins Group enriched duodenum: 186.1 gallbladder: 100.6 kidney: 93.3 small intestine: 266.6 testis: 92.6
ANXA13 Annexin A13 Plasma proteins Predicted intracellular proteins Plasma membrane Group enriched duodenum: 304.7 fallopian tube: 91.6 gallbladder: 228.3 small intestine: 240.9
B3GALT5 UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 Predicted intracellular proteins Predicted secreted proteins Group enriched colon: 23.1 duodenum: 28.2 gallbladder: 8.6 rectum: 41.3 small intestine: 37.9
CLRN3 Clarin 3 Predicted membrane proteins Transporters Group enriched colon: 71.2 duodenum: 75.4 gallbladder: 23.7 kidney: 43.9 liver: 40.2 rectum: 77.5 small intestine: 99.5
CYP2C18 Cytochrome P450, family 2, subfamily C, polypeptide 18 Enzymes Plasma proteins Predicted secreted proteins Group enriched duodenum: 105.9 esophagus: 24.7 gallbladder: 24.5 liver: 97.7 small intestine: 90.0 stomach: 62.7
EPS8L3 EPS8-like 3 Predicted intracellular proteins Vesicles Group enriched colon: 76.3 duodenum: 156.3 gallbladder: 60.0 rectum: 87.4 small intestine: 170.4 stomach: 54.0
ERN2 Endoplasmic reticulum to nucleus signaling 2 Enzymes Predicted membrane proteins Predicted secreted proteins Group enriched cervix, uterine: 26.7 colon: 27.8 duodenum: 12.7 gallbladder: 25.2 rectum: 23.4 small intestine: 10.1 stomach: 49.9
HHLA2 HERV-H LTR-associating 2 Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Group enriched colon: 89.3 duodenum: 89.6 gallbladder: 46.3 rectum: 92.1 small intestine: 146.8
HTR1D 5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Group enriched duodenum: 9.7 gallbladder: 2.5 small intestine: 9.3
LRRC19 Leucine rich repeat containing 19 Predicted membrane proteins Group enriched colon: 36.8 duodenum: 24.4 gallbladder: 9.5 kidney: 45.4 rectum: 36.2 small intestine: 35.4
NR1I2 Nuclear receptor subfamily 1, group I, member 2 FDA approved drug targets Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors Nucleoplasm Group enriched colon: 9.3 duodenum: 23.2 gallbladder: 6.0 liver: 19.7 rectum: 9.4 small intestine: 26.3
PPP1R14D Protein phosphatase 1, regulatory (inhibitor) subunit 14D Predicted intracellular proteins Group enriched colon: 107.5 duodenum: 114.3 gallbladder: 24.3 rectum: 101.6 small intestine: 91.7
SLC15A1 Solute carrier family 15 (oligopeptide transporter), member 1 Predicted membrane proteins Transporters Nucleoplasm Cytosol Group enriched duodenum: 157.7 gallbladder: 68.0 small intestine: 230.1
SLC17A4 Solute carrier family 17, member 4 Predicted membrane proteins Transporters Group enriched colon: 20.8 duodenum: 29.4 gallbladder: 25.5 liver: 22.4 rectum: 29.4 small intestine: 35.7
TM4SF4 Transmembrane 4 L six family member 4 Predicted membrane proteins Transporters Plasma membrane Cytosol Group enriched duodenum: 595.8 gallbladder: 1326.5 liver: 343.7 small intestine: 515.2
UGT1A5 UDP glucuronosyltransferase 1 family, polypeptide A5 Enzymes Predicted membrane proteins Group enriched duodenum: 7.7 gallbladder: 3.9 small intestine: 6.9
UGT2B15 UDP glucuronosyltransferase 2 family, polypeptide B15 Enzymes Predicted membrane proteins Group enriched colon: 23.8 duodenum: 30.6 gallbladder: 114.5 liver: 108.6 small intestine: 33.9
VNN1 Vanin 1 Enzymes Plasma proteins Predicted secreted proteins Group enriched duodenum: 176.1 gallbladder: 175.5 liver: 142.6 small intestine: 108.8
Page
of 1